HUMA — Humacyte Cashflow Statement
0.000.00%
Last trade - 00:00- $203.21m
- $174.81m
Annual cashflow statement for Humacyte, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -66.5 | -26.5 | -12 | -111 | -149 |
| Depreciation | |||||
| Non-Cash Items | 4.97 | -62.4 | -68.4 | 23.2 | 43.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.37 | -0.557 | 1.03 | 6.57 | 0.311 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -55.6 | -81.2 | -71.1 | -73.3 | -98.1 |
| Capital Expenditures | -0.318 | -0.22 | -1.05 | -2.28 | -1.57 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.05 | -8 | 5.89 | 2.11 | 0 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.268 | -8.22 | 4.84 | -0.173 | -1.57 |
| Financing Cash Flow Items | 0 | -3.94 | 0 | 38 | 19.4 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.05 | 267 | -1.45 | 4.51 | 114 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -53.8 | 178 | -67.7 | -69 | 14.5 |